Şunu aradınız:: homocystinúriou (Slovakça - İngilizce)

liečba cystadane musí byť vedená lekárom skúseným v oblasti starostlivosti o pacientov s homocystinúriou.
cystadane treatment should be supervised by a physician experienced in the treatment of patients with homocystinuria.

užívanie tohto lieku bude vedené lekárom skúseným v oblasti starostlivosti o pacientov s homocystinúriou.
the use of this medicine will be supervised by a doctor experienced in the treatment of patients with homocystinuria.

pacienti s homocystinúriou nemôž premeniť homocysteín na cysteín, a tak sa homocysteín zhromažďuje v krvi a moči.
patients with homocystinuria cannot convert homocysteine into cysteine, so homocysteine builds up in the blood and urine.

na liečbu liečbu cystadane musí vždy dohliadať lekár, ktorý má skúsenosti v liečbe pacientov s homocystinúriou.
treatment with cystadane should be supervised by a doctor who has experience in the treatment of patients with homocystinuria.

ukázalo sa, že doplnenie bezvodného betaínu zlepšuje stavy metabolických anomálií v mozgovomiechovej tekutine u pacientov s homocystinúriou.
betaine anhydrous supplementation was shown to improve the metabolic abnormalities in the cerebrospinal fluid of patients with homocystinuria.

zahŕňalo to 202 správ, ktoré popisovali účinky cystadanu, podávaného v rôznych dávkach, na hladiny homocysteínu u pacientov s homocystinúriou rôzneho veku.
this included 202 reports that described the effects of cystadane, given at a variety of doses, on homocysteine levels in homocystinuria patients of various ages.

keďže počet pacientov s homocystinúriou je nízky, toto ochorenie je zriedkavé a cystadane bol dňa 9. júla 2001 označený ako ‘liek na ojedinelé ochorenia’.
because the number of patients with homocystinuria is low, the disease is considered ‘rare’, and cystadane was designated an ‘orphan medicine’ (a medicine used in rare diseases) on 9 july 2001.